| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |